Neo Ivy Capital Management’s Oscar Health OSCR Stock Holding History

Neo Ivy Capital Management’s Portfolio OSCR Stock Details OSCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-270,126	Closed	-$3.1M	–	459
2026 Q1	$3.1M	Sell	270,126 -161,046	-37%	-$2.27M	0.82%	23
2025 Q4	$6.2M	Buy	431,172 +264,812	+159%	+$4.58M	0.98%	18
2025 Q3	$3.15M	Buy	166,360 +77,680	+88%	+$1.28M	0.77%	29
2025 Q2	$1.9M	Buy	+88,680	New	+$1.32M	0.61%	52
2025 Q1	–	Sell	-26,727	Closed	-$359K	–	390
2024 Q4	$359K	Sell	26,727 -1,539	-5%	-$24.8K	0.07%	199
2024 Q3	$600K	Buy	+28,266	New	+$509K	0.19%	178

Other funds holding OSCR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

TCMNY

Thrive Capital Management (New York) New York $3.81B AUM 45.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Neo Ivy Capital Management's OSCR Position: Q2 2026 in Review

Neo Ivy Capital Management sold out of Oscar Health (OSCR) in Q2 2026, closing a stake of 270,126 shares — an estimated $3.1M sold.

Neo Ivy Capital Management first reported a position in OSCR in Q3 2024 and held it in 6 quarters. The position peaked at $6.2M in Q4 2025. 403 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

Neo Ivy Capital Management reported no remaining Oscar Health position as of Q2 2026 after selling out during the quarter.
Neo Ivy Capital Management sold 270,126 Oscar Health shares in Q2 2026, an estimated $3.1M.
Neo Ivy Capital Management first reported a position in Oscar Health in Q3 2024 and held it in 6 quarters.
Neo Ivy Capital Management's Oscar Health position peaked at $6.2M in Q4 2025.
403 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Neo Ivy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.